维普期刊资源整合服务平台（V6.5）

22篇 您的检索式：作者名="Massidda B"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Usefulness of pyridinium crosslinks and CA15-3 as markers in metastatic bone breast carcimoma 显示文摘	Massidda B Ionta MT Foddi MR	1996	Anticancer Res1996，16，：	1
2	Molecular alterations in key-regulator genes among patients with T4 breast carcinoma显示文摘	Massidda B Sini M Budroni M etc	2010	BMC Cancer2010，10，：	1
3	Usefulness of Pyridinium Crosslinks and CA153 as Markers in Metastatic Bone Breast Carcinoma显示文摘	Massidda B Ionta M T Foddi M R	1996	Anticancer Res1996，16，4：	1
4	Prevention of non-cisplatin induced emesis:role of the antagonists of 5-HT3 receptors显示文摘	Massidda B Laconi S Froddi MR	1994	Ann Oncol1994，5，8：	1
5	Prevention of delayed emesis by a single intravenous bolus dose of 5-HT3-receptor-antagonist in moderately emetogenic chemotherapy显示文摘	Massidda B Ionta MT	1996	J Chemother1996，8，3：	1
6	usefulness of pyridinium crosslinks and CA153 as markers in metastatic bone brest carcionoma显示文摘	Ionta MT	1996	Anticancer Res1996，16，4：	1
7	Usefulness of phridinium crosslinks and CA15-3 as markers in metastatic bone breast cancinoma显示文摘	MASSIDDA B LONTA M T FODDI M R		0，，22：	1
8	Molecular alterations in key-regulator genes among patients with T4 breast carcinoma显示文摘	Massidda B Sini M Budroni M		0，，：	1
9	Usefulness of pyridini um crosslihks and CA153 as markers in metastatic bone breast carcinoma显示文摘	Massidda B Ionta MT Foddi MR	1996	Anticancer Res1996，16，4：	1
10	Usefulness of phridinium crosslinks and CA15-3 as markers in metastatic bone breast carcinoma显示文摘	Lonta M T Foddi M R	1996	AnticancerRes1996，16，：	1
11	A phase Ⅱ study of gemcitabine and tamoxifen in advanced pancreatic cancer显示文摘	Tomao S Romiti A Massidda B	2002	Antieancer Res2002，22，4：	1
12	Usefulness of pyridinium crosslinks and CA153 as markers in metastatic bone breast carcinoma显示文摘	Massidda B Lonta MT Foddi MR	2004	Anticancer Res2004，16，4：	1
13	Usefulness of pyridinium crosslinks and CA153 as markeers in metastatic bone breast carcinoma显示文摘	Massidda B Lonta MT Forddi MR		0，，：	1
14	Usefulness ofpyridinium crosslinks and CA 153as markers in metastatic bone breast carcinoma显示文摘	Massidda B Ionta MT	1996	Anticancer Res1996，16，4：	1
15	Usefulness of pyridinium crosslinks and CA153 as markers in metastatic bone breast carcionoma显示文摘	Massidda B Iortta MT Foddi MR	1996	Anti- cancer Res1996，16，4：	1
16	Usefulness of pyridinium crosslinks and CA 15-3 as markers in metastatic bone breast carcinoma显示文摘	Massidda B Ionta MT Foddi MR	1996	AnticancerRes1996，16，4：	1
17	Usefulness of pyridinium crosslinks and CA15-3 as marks in metastatic bone brest carcinoma显示文摘	Massidda B Lonta MT Forddi MR	1996	Anticancer Res1996，16，4：	1
18	Usefulness ofpyridinium crosslinks and CA153 as markers in metastatic bone breast carcinoma显示文摘	Massidda B Ionta MT Foddi MR	1996	Anticancer Res1996，16，4：	1
19	Usefulness of pyridinium crosslinks and CA15-3 as markers in metastatic bone breast carcinoma显示文摘	Massidda B Ionta MT Foddi MR	1996	Anticancer Res1996，16，4：	1
20	Intra-patient alternated dose escalation of paclitaxel and gemcitabine versus paclitaxel followed by fixed dose rate infusion of gemcitabine in fit elderly non-small cell lung cancer patients: A Southern Italy Cooperative Oncology Group randomized phase Ⅱ trial 显示文摘	COMELLA P PUTZU C MASSIDDA B	2007	Lung Cancer2007，56，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示